• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 3. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 4. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 5. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenols Methoxyphenols

Junipediol A: A Comprehensive Overview

Junipediol A (CAS No. 86548-91-6) is a bioactive compound that has garnered significant attention in the scientific community due to its unique properties and potential applications. This compound, isolated from natural sources, has been extensively studied for its role in various biological systems. Recent advancements in analytical techniques and molecular biology have shed new light on its structure, function, and therapeutic potential.

The chemical structure of Junipediol A is characterized by a complex arrangement of functional groups that contribute to its bioactivity. Researchers have employed advanced spectroscopic methods, including NMR and mass spectrometry, to elucidate its molecular architecture. These studies have revealed that Junipediol A exhibits a high degree of structural diversity, which is often associated with potent biological effects. Its unique chemical properties make it a promising candidate for drug development and biotechnological applications.

Recent studies have focused on the biological activity of Junipediol A, particularly its potential as an anti-inflammatory and antioxidant agent. Experimental data indicate that Junipediol A can modulate key signaling pathways involved in inflammation and oxidative stress, suggesting its therapeutic potential in conditions such as neurodegenerative diseases and cardiovascular disorders. Furthermore, preclinical trials have demonstrated its ability to enhance cellular resilience against environmental stressors, highlighting its role in promoting overall health and well-being.

The synthesis and purification of Junipediol A have also been the subject of intense research. Scientists have developed novel synthetic routes to produce this compound in large quantities while maintaining its structural integrity. These advancements have not only improved the availability of Junipediol A for experimental purposes but also paved the way for its commercialization in the pharmaceutical and nutraceutical industries.

In terms of applications, Junipediol A has shown promise in the fields of cosmetics and skincare. Its ability to protect skin cells from UV-induced damage has led to its incorporation into sunscreen formulations. Additionally, ongoing research explores its potential as a natural preservative in food products, leveraging its antimicrobial properties to extend shelf life without compromising safety or taste.

The safety profile of Junipediol A is another critical area of investigation. Regulatory agencies require rigorous testing to ensure that this compound meets safety standards before it can be approved for human use. Recent toxicological studies indicate that Junipediol A exhibits low toxicity at therapeutic doses, making it a safer alternative to synthetic compounds with known adverse effects.

Looking ahead, the future of Junipediol A research is poised for exciting developments. Collaborative efforts between academia and industry are expected to accelerate the translation of basic science into practical applications. The integration of artificial intelligence and machine learning into drug discovery pipelines may further enhance our understanding of Junipediol A's mechanisms of action and optimize its therapeutic potential.

In conclusion, Junipediol A (CAS No. 86548-91-6) represents a cutting-edge compound with multifaceted applications across various industries. Its unique chemical properties, coupled with emerging research findings, position it as a key player in the development of innovative solutions for healthcare, cosmetics, and food science. As research continues to unfold, the full extent of Junipediol A's capabilities will undoubtedly reveal new opportunities for enhancing human health and well-being.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)